FY2025 · ended Dec 31, 2025 · Revenue $5.05M, +5.4% YoY · Filed Mar 31, 2026
Scientific Industries, Inc. (SCND) files with the SEC under industry code 3826, Laboratory Analytical Instruments. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $5.1 million and a net loss of $1.2 million. Free cash flow was -$8.2 million. As of Jun 30, 2026 it held $4.5 million in cash and investments and $790,700 in total debt.
Revenue (TTM)
$5.73M
+239.0% vs year-ago TTM
Net income (TTM)
$-741,300
+88.4% vs year-ago TTM
Operating cash flow
$-8.15M
-121.2% vs prior year
Free cash flow
$-8.21M
-117.1% vs prior year
EPS (TTM)
$-0.06
+89.6% vs year-ago TTM
Dividend per share
None
Shares outstanding
11.93M
+13.6% vs prior year
Net cash
$3.76M
as of Jun 30, 2026
Operating margin
-120.8%
FY 2026
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- SCND (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bohemia, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 87802
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Jun 30, 2022 |
FY 2020 Jun 30, 2021 |
|---|---|---|---|---|---|
| Revenue | $5.1M | $4.8M | $11.1M | $11.4M | $9.8M |
| Operating income | -$7.9M | -$8.2M | -$9.3M | -$11.5M | -$4.7M |
| Net income | -$1.2M | -$6.4M | -$9.1M | -$13.7M | -$3.7M |
| Diluted EPS | -$0.11 | -$0.61 | — | — | -$1.00 |
| Operating cash flow | -$8.1M | -$3.7M | -$6.2M | -$5.2M | -$3.3M |
| Free cash flow | -$8.2M | -$3.8M | -$6.3M | -$5.9M | -$3.5M |
| Total assets | $12.6M | $11.6M | $16.7M | $21.0M | $29.0M |
| Total liabilities | $1.9M | $2.4M | $2.8M | $3.5M | $2.8M |
| Stockholders' equity | $10.7M | $9.1M | $13.9M | $17.5M | $26.2M |
| Cash and investments | $955,000 | $587,900 | $796,100 | $9.4M | $13.4M |
| Total debt | $977,400 | $1.0M | $1.3M | $1.5M | $731,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Oct 2, 2026 | Oct 1, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Auditor change
|
Jan 20, 2026 | Jan 14, 2026 |
| 8-K/A |
Amended current report
Material agreement, Acquisition or sale of assets
|
Dec 5, 2025 | Aug 7, 2025 |
All 711 Scientific Industries, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.